The chemistry of cadinenes and cadinols

doi:10.1016/0040-4020(58)80046-0

Tetrahedron

Volume 4, Issues 3–4, 1958, Pages 246-255

https://doi.org/10.1016/0040-4020(58)80046-0 Get rights and content

Abstract

A number of sesquiterpenoid hydrocarbons, the cadinenes, and tertiary alcohols, the cadinols, have been isolated in a pure state in these Laboratories during the past few years. Their constitution and absolute configuration have been established. This review is intended to be a brief survey of the history of these compounds as well as a summary of our results.

References (53)

K. Kafuku et al.
Bull. Chem. Soc. Japan
(1931)
Chem. Abstr.
(1931)
J. Simonsen et al.
(1952)
Elsevier's Encyclopedia of Organic Chemistry (Edited by F. Radt) Ser. III, Vol. 12B, pp. 176–188, 322–324 and...
A.J. Haagen-Smit
Fortschr. Chem. Org. Naturstoffe
(1955)
D.H.R. Barton
Quart. Rev.
(1957)
E. Soubeiran et al.
Liebigs Ann.
(1840)
O. Wallach
Liebigs Ann.
(1892)
L. Ruzicka
(1928)
W.P. Campbell et al.
J. Amer. Chem. Soc.
(1942)
F.W. Semmler et al.
Ber. Dtsch. Chem. Ges.
(1914)

L. Ruzicka et al.

Helv. Chim. Acta

(1924)

O. Motl et al.

Chem. Listy

(1958)

D.H.R. Barton et al.

J. Chem. Soc.

(1957)

J.D. Briasco et al.

J. Appl. Chem.

(1952)

V. Herout et al.

Chem. Listy

(1953)

V. Herout et al.

Coll. Trav. Chim. Tchécosl.

(1953)

K.K. Chakravarti et al.

Perf. & Ess. Oil Rec.

(1955)

B.B. Ghatgey et al.

Perf. & Ess. Oil Rec.

(1956)

K. Kafuku et al.

J. Chem. Soc. Japan

(1932)

Chem. Abstr.

(1933)

V. Sýkora and V. Herout, Chem. Listy In...

S. Dev et al.

J. Indian Chem. Soc.

(1949)

V. Herout et al.

Chem. Listy

(1952)

F. Šorm et al.

Chem. Listy

(1952)

F. Šorm et al.

Coll. Trav. Chim. Tchécosl.

(1953)

F. Vonášek. Private...

J. Plíva et al.

Chem. Listy

(1952)

J. Plíva et al.

Coll. Trav. Chim. Tchécosl.

(1953)

V. Herout et al.

Chem. Listy

(1953)

V. Herout et al.

Coll. Trav. Chim. Tchécosl.

(1954)

P.A. Plattner et al.

Helv. Chim. Acta

(1942)

Cited by (20)

Medicine in motion: Opportunities, challenges and data analytics-based solutions for traditional medicine integration into western medical practice
2021, Journal of Ethnopharmacology
Citation Excerpt :
In one of the pairwise comparisons, 121 compounds were shared between the 2 (one Kampo and one TCM) formulations. These were then re-categorised (Fig. 2) using literature analysis into opioid/alkaloid candidate analgesics (alkaloids related to known opioid receptor ligands or ion channel ligands, 4 convergent compounds) (Bienz et al., 2002; Kai et al., 1998; National Center for Biotechnology Information; Nichols and Lee, 2018; Qi et al., 2019; Saeed et al., 1997; Song et al., 2000; Xu et al., 2005; Zhong et al., 1995), potential ligands for nociceptive ion channels (terpenes, 49 convergent compounds), components with other demonstrated neuroactivity (15 convergent compounds), components with bioactivity indirectly related to pain (anti-inflammatory, anti-oxidants, 16 convergent compounds) and compounds with other types of bioactivity but no obvious link to analgesia (56 convergent compounds) (Antwi et al., 2018; Bommareddy et al., 2019; Crupi and Cuzzocrea, 2017; Devi et al., 2015; Do et al., 2019; Henry and Maisch, 1890; Herout and Sykora, 1958; Huang et al., 2015; Hui et al., 2015; Kimura et al., 2001; Ko et al., 2017; Kumar and Muller, 2000; Kwon et al., 2018; Le et al., 2018; Li et al., 2009; Madeo et al., 2018; National Center for Biotechnology Information; Ng et al., 2008; Qian, 2002; Shim et al., 2018; Wang et al., 2019; Ye et al., 2018; Zeisel, 1981). These data are summarized in Fig. 1.
Traditional pharmacopeias have been developed by multiple cultures and evaluated for efficacy and safety through both historical/empirical iteration and more recently through controlled studies using Western scientific paradigms and an increasing emphasis on data science methodologies for network pharmacology. Traditional medicines represent likely sources of relatively inexpensive drugs for symptomatic management as well as potential libraries of new therapeutic approaches. Leveraging this potential requires hard evidence for efficacy that separates science from pseudoscience.
We performed a review of non-Western medical systems and developed case studies that illustrate the epistemological and practical translative barriers that hamper their transition to integration with Western approaches. We developed a new data analytics approach, in silico convergence analysis, to deconvolve modes of action, and potentially predict desirable components of TM-derived formulations based on computational consensus analysis across cultures and medical systems.
Abstraction, simplification and altered dose and delivery modalities were identified as factors that influence actual and perceived efficacy once a medicine is moved from a non-Western to Western setting. Case studies on these factors highlighted issues with translation between non-Western and Western epistemologies, including those where epistemological and medicinal systems drive markets that can be epicenters for zoonoses such as the novel Coronavirus. The proposed novel data science approach demonstrated the ability to identify and predict desirable medicinal components for a test indication, pain.
Relegation of traditional therapies to the relatively unregulated nutraceutical industry may lead healthcare providers and patients to underestimate the therapeutic potential of these medicines. We suggest three areas of emphasis for this field: First, vertical integration and embedding of traditional medicines into healthcare systems would subject them to appropriate regulation and evidence-based practice, as viable integrative implementation mode. Second, we offer a new Bradford-Hill-like framework for setting research priorities and evaluating efficacy, with the goal of rescuing potentially valuable therapies from the nutraceutical market and discrediting those that are pseudoscience. Third, data analytics pipelines offer new capacity to generate new types of TMS-inspired medicines that are rationally-designed based on integrated knowledge across cultures, and also provide an evaluative framework against which to test claims of fidelity and efficacy to TMS made for nutraceuticals.
Sesquiterpenes from leaves of Cryptomeria japonica
1995, Phytochemistry
Twenty-seven sesquiterpenes were isolated from leaves of Cryptomeria japonica. The new compounds included elem-1-en-4,11-diol, 11-acetoxyeudesman-4α-ol, eudesmane-5α,11-diol, 3-eudesmene-1β,11-diol, 1β-acetoxy-3-eudesmen-11-ol, 4-eudesmene-1β,11-diol, 1β-acetoxy-4-eudesmen-11-ol, 7-epi-γ-eudesmol, 7-epi-4-eudesmene-1β,11-diol, 1β-acetoxy-4(15)-eudesmen-11-ol. Their structures were determined by chemical and spectral methods.
Naturally occurring cadinenes
1989, Phytochemistry
The total stereostructure of (-)-muurolene dihydrochloride
1983, Tetrahedron Letters
Configurations and conformations of torreyol (δ-cadinol), α-cadinol, T-muurolol and T-cadinol
1981, Tetrahedron
The configurations and conformations of torreyol (6; “δ-cadinol”,10α-hydroxy-4-muurolene), α-cadinol (7; 10α-hydroxy-4-cadinene), T-muurolol (8; 10β-hydroxy-4-muurolene), and T-cadinol (9; 10β-hydroxy-4-cadinene) have been determined by an extensive PMR study using lanthanide-induced shifts. Characteristic mass spectrometric fragmentation patterns of muurolols and cadinols are briefly discussed.
Neue diterpene und neue dihydrochalkon-derivate sowie weitere inhaltsstoffe aus Helichrysum-arten
1980, Phytochemistry

View all citing articles on Scopus

View full text

The chemistry of cadinenes and cadinols

Abstract

Bull. Chem. Soc. Japan

Chem. Abstr.

Fortschr. Chem. Org. Naturstoffe

Quart. Rev.

Liebigs Ann.

Liebigs Ann.

J. Amer. Chem. Soc.

Ber. Dtsch. Chem. Ges.

Helv. Chim. Acta

Chem. Listy

J. Chem. Soc.

J. Appl. Chem.

Chem. Listy

Coll. Trav. Chim. Tchécosl.

Perf. & Ess. Oil Rec.

Perf. & Ess. Oil Rec.

J. Chem. Soc. Japan

Chem. Abstr.

J. Indian Chem. Soc.

Chem. Listy

Chem. Listy

Coll. Trav. Chim. Tchécosl.

Chem. Listy

Coll. Trav. Chim. Tchécosl.

Chem. Listy

Coll. Trav. Chim. Tchécosl.

Helv. Chim. Acta